Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).
about
The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer AgentVitamins and MelanomaVitamin D deficiency is associated with a worse prognosis in metastatic melanoma.Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo modelsOn the role of classical and novel forms of vitamin D in melanoma progression and management.Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.
P2860
Q26749030-814A766C-0C64-45B2-9A62-0F777B95F256Q26799314-5C25DE73-95F6-4A4A-957D-BF75F990DA96Q37701695-14BB7765-2382-4C3F-98F1-FFBB5EAAA108Q37706071-A8690C3C-1657-40FB-96AE-7D05ED7169D5Q38662850-C7A4FA89-6C2C-431F-83B6-8FDE0B648F72Q41351502-E9C9DAAE-65CA-4D02-B9E2-AB09ADED81C4Q41507036-93639A3F-E411-4189-9BC6-82F5F29BDDDDQ48218051-B07F40F1-3497-4BC2-A759-33C1D37F642AQ55069227-4F70C066-7CB2-4E89-BBE6-446000584D7E
P2860
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@ast
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@en
Adjuvant therapy with high dos ...... lled randomised phase II trial
@nl
type
label
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@ast
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@en
Adjuvant therapy with high dos ...... lled randomised phase II trial
@nl
prefLabel
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@ast
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@en
Adjuvant therapy with high dos ...... lled randomised phase II trial
@nl
P2093
P2860
P921
P356
P1433
P1476
Adjuvant therapy with high dos ...... II trial (ANZMTG 02.09 Mel-D).
@en
P2093
Andrew J Spillane
John F Thompson
Jonathan R Stretch
Kerwin F Shannon
Rebecca S Mason
Robyn P M Saw
P2860
P2888
P356
10.1186/1471-2407-14-780
P407
P577
2014-10-24T00:00:00Z
P5875
P6179
1012253784